Glucose restriction induces ROS-AMPK-mediated CTR1 expression and increases cisplatin efficiency in NSCLC. Zhang P, Li B, Chen Q, Wang H, et al. Cancer Lett 2022;543:215793.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang P, Li B, Chen Q, Wang H, et al. Glucose restriction induces ROS-AMPK-mediated CTR1 expression and increases cisplatin efficiency in NSCLC. Cancer Lett 2022;543:215793.
PMID: 35716782